2014
DOI: 10.1016/j.molonc.2014.03.020
|View full text |Cite
|
Sign up to set email alerts
|

RalA signaling pathway as a therapeutic target in hepatocellular carcinoma (HCC)

Abstract: Ral (Ras like) leads an important proto-oncogenic signaling pathway down-stream of Ras. In this work, RalA was found to be significantly overactivated in hepatocellular carcinoma (HCC) cells and tissues as compared to non-malignant samples. Other elements of RalA pathway such as RalBP1 and RalGDS were also expressed at higher levels in malignant samples. Inhibition of RalA by gene-specific silencing caused a robust decrease in the viability and invasiveness of HCC cells. Additionally, the use of geranyl-gerany… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
36
1

Year Published

2014
2014
2022
2022

Publication Types

Select...
7
1

Relationship

2
6

Authors

Journals

citations
Cited by 39 publications
(38 citation statements)
references
References 30 publications
1
36
1
Order By: Relevance
“…RALGPS2 has highest expression in the testis or brain [56, 57]. It is suggested that RALGPS2 functions as an inhibitor of RalA signaling and thereby decreases tumor cell proliferation and induces apoptosis [58, 59]. The role of RALGPS2 in endothelial cells is probably different, because no cell death was observed during our 7-day tube formation assay.…”
Section: Discussionmentioning
confidence: 99%
“…RALGPS2 has highest expression in the testis or brain [56, 57]. It is suggested that RALGPS2 functions as an inhibitor of RalA signaling and thereby decreases tumor cell proliferation and induces apoptosis [58, 59]. The role of RALGPS2 in endothelial cells is probably different, because no cell death was observed during our 7-day tube formation assay.…”
Section: Discussionmentioning
confidence: 99%
“…The interplay between pathways is related to the ability of the Ras protein to activate, besides Raf, several other downstream effectors such as, for instance, the PI3 kinase, the RalGDS, the PLCε and the TIAM1 proteins. Activation of these effectors may be implicated in hepatocarcinogenesis as an enhanced expression of RalGDS and its downstream effector RalA is described in HCC cell lines and in HCC mouse models . Moreover, TIAM1 is associated with a poor prognosis in patients with HCC and contributes to tumour invasion and metastasis .…”
Section: Signalling Crosstalk Influencing Ras/mapk Pathway Activity Imentioning
confidence: 99%
“…A role for RalB was not addressed. Finally, in a transgenic mouse model for HCC (farnesoid X receptor–deficiency induced) elevated RalA-GTP was detected in the liver tumors [111]. …”
Section: Ral and Cancermentioning
confidence: 99%